Cargando…
Prediction of survival benefits from progression-free survival benefits in advanced non-small-cell lung cancer: evidence from a meta-analysis of 2334 patients from 5 randomised trials
OBJECTIVES: To investigate whether progression-free survival (PFS) can be considered a surrogate endpoint for overall survival (OS) in advanced non-small-cell lung cancer (NSCLC). DESIGN: Meta-analysis of individual patient data from randomised trials. SETTING: Five randomised controlled trials comp...
Autores principales: | Laporte, Silvy, Squifflet, Pierre, Baroux, Noémie, Fossella, Frank, Georgoulias, Vassilis, Pujol, Jean-Louis, Douillard, Jean-Yves, Kudoh, Shinzohy, Pignon, Jean-Pierre, Quinaux, Emmanuel, Buyse, Marc |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BMJ Publishing Group
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3612819/ https://www.ncbi.nlm.nih.gov/pubmed/23485717 http://dx.doi.org/10.1136/bmjopen-2012-001802 |
Ejemplares similares
-
Hysteroscopic Resection for Missed Abortion: Feasibility, Operative Technique and Potential Benefit Compared to Curettage
por: de Codt, Matthieu, et al.
Publicado: (2020) -
Extrapolation of Survival Curves from Cancer Trials Using External Information
por: Guyot, Patricia, et al.
Publicado: (2016) -
Bias and precision of methods for estimating the difference in restricted mean survival time from an individual patient data meta-analysis
por: Lueza, Béranger, et al.
Publicado: (2016) -
Erratum to: Bias and precision of methods for estimating the difference in restricted mean survival time from an individual patient data meta-analysis
por: Lueza, Béranger, et al.
Publicado: (2016) -
Matching Graft Quality to Recipient’s Disease Severity Based on the Survival Benefit in Liver Transplantation
por: Winter, Audrey, et al.
Publicado: (2020)